Bank Loans, MLPs Be...
Health Care: Drugs
Insmed Inc. (INSM: NASDAQ)
$12.44 1.11 | 9.80%
05/22/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -41.37M | -59.66M | -6.43M | 118.35M |
| Operating Gains/Losses | -5.00K | -1.00K | 0.00 | -127.47M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 757.00K | -286.00K | 2.04M | -2.15M |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 4.73M | 884.00K | -2.75M | -965.00K |
| (Decrease) Increase In Other Current Liabilities | 663.00K | 1.55M | -922.00K | -1.90M |
| (Increase) Decrease In Other Working Capital | 1.41M | -402.00K | 0.00 | -36.00K |
| Other Non-Cash Items | 2.19M | 27.59M | 366.00K | 2.54M |
| Net Cash From Continuing Operations | -31.01M | -30.20M | -7.72M | -11.01M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -31.01M | -30.20M | -7.72M | -11.01M |
| Sale of Property, Plant & Equipment | 5.00K | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 81.46M | 36.50M | 115.15M | 0.00 |
| Purchases of Property, Plant & Equipment | -290.00K | -979.00K | 0.00 | 0.00 |
| Acquisitions | 0.00 | 0.00 | -6.73M | 0.00 |
| Purchases of Short-Term Investments | -19.66M | -1.16M | -102.46M | -108.74M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 127.47M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 61.52M | 34.36M | 5.96M | 18.74M |
| Issuance of Debt | 20.00M | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 25.87M | 32.00K | 0.00 | 580.00K |
| Repayment of Long-Term Debt | -120.00K | -82.00K | -237.00K | -1.25M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -328.00K | 0.00 | 4.00K | 3.53M |
| Net Cash From Financing Activities | 45.42M | -50.00K | -233.00K | 2.87M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 75.93M | 4.10M | -2.00M | 10.60M |
Portfolios with INSM
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- Userbetterlatethannever
- UserStock Choices
- Userjstanley Portfolio 1
- Userlgselsorlaw Portfolio 1
- Userkazooskibum
- Usersmercado
- UserMr. T fund
- UserLorirain II
Latest INSM Headlines from TheStreet
- Programmed Insider Buying? Yes, at Insmed and United Therapeutics 01.24.13 | 08:01 am
- 4 Plays Under $10 on the Rise 11.13.12 | 05:11 pm
- Insmed's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.07.12 | 01:08 pm
- 5 Under-$10 Stocks Poised for a Breakout 06.07.12 | 02:06 pm
- Insmed Stock Gaps Down On Today's Open (INSM) 10.10.11 | 09:10 am
- Insmed Inc. Stock Downgraded (INSM) 08.22.11 | 08:08 am
- Insmed Stock Soars (INSM) 08.11.11 | 03:08 pm
- 'Strong Rally' in Small-Caps May Emerge 08.09.11 | 10:08 am
- Insmed Stock Gaps Down On Today's Open (INSM) 08.02.11 | 09:08 am
- Insmed Inc. Stock Upgraded (INSM) 07.22.11 | 07:07 am
Press Releases for INSM
- The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Directors Of Insmed Incorporated In Connection With Executive Compensation - PR Newswire 01.17.13 | 02:01 pm
- Insmed To Present At 31st Annual J.P. Morgan Healthcare Conference - PR Newswire 12.13.12 | 08:12 am
- Insmed Announces CLEAR-108 Phase 3 Clinical Study Of ARIKACE® In Cystic Fibrosis Patients With Pseudomonas Lung Infections Has Completed Target Enrollment - PR Newswire 11.13.12 | 08:11 am
- Insmed To Present At Two Upcoming Investor Conferences - PR Newswire 11.12.12 | 08:11 am
- Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler As Chief Financial Officer - PR Newswire 11.07.12 | 07:11 am
- Insmed Appoints Will Lewis As President And Chief Executive Officer - PR Newswire 09.11.12 | 08:09 am
- Insmed To Present At Stifel Nicolaus 2012 Healthcare Conference - PR Newswire 08.30.12 | 08:08 am
- Insmed To Present At 2012 Wedbush PacGrow Life Sciences Management Access Conference - PR Newswire 08.14.12 | 08:08 am
- Pharmaceutical Industry Veteran Al Altomari Elected To Insmed's Board Of Directors - PR Newswire 08.06.12 | 08:08 am
- Insmed Receives Second Composition Of Matter Patent For ARIKACE® - PR Newswire 08.02.12 | 08:08 am
Partner Headlines for INSM
- Benzinga's Microcap Movers for Friday January 20, 2012 - Benzinga 01.22.12 | 10:01 am
- November's Low Price To Book Stocks Vs. Bankruptcy Risks - Seeking Alpha 11.04.11 | 08:11 am
- BMS Drug Deemed Too Costly: Weekly Round-Up Of Biotech Failures And Mishaps - Seeking Alpha 10.16.11 | 08:10 am
- Buy And Sell Ideas Based On Monday's Big Biotech News Movers - Seeking Alpha 10.11.11 | 08:10 am
- Thursday's Top Performing Small Cap Stocks (AONE, AIQ, KV.A, INSM, CXPO) - NASDAQ 08.12.11 | 03:08 pm
- 6 Stocks With New Uptrends - Seeking Alpha 05.26.11 | 07:05 am
- Portfolio Moves in a Volatile Market - Seeking Alpha 05.09.10 | 05:05 am
